Risk factors

Achieve Life Sciences (ACHV) risk factors

Item 1A of every Achieve Life Sciences, Inc. 10-K on file, and what changed from one year to the next.

Open ACHV in Gloomberb →
  • FY2025 10-K risk factors

    78 risks, 12 new, 10 dropped, 20 reworded since the prior year. Achieve Life Sciences faces financial distress with $15.0 million in debt and negative cash flow.

    Filed Mar 24, 2026
  • FY2024 10-K risk factors

    76 risks. Achieve Life Sciences relies entirely on a single clinical product candidate, cytisinicline, sourced from a single Bulgarian supplier, Sopharma AD. The company faces significant financial risks, including $10.0 million in debt as of December 31, 2024, and a complete lack of product revenue.

    Filed Mar 11, 2025